The orphan receptor NR4Al (Nur77, TR3, NGFI-B) is overexpressed in many different cancer cell lines and tumors, and, in leukemia cells, NR4Al is also more highly expressed than in B- or T-cell. In contrast, we observed the opposite pattern of NR4A2 (Nurrl) expression in these same cells. NR4Al is primarily oncogenic in cancer cell lines and is a target for inhibitors or inactivators and treatment of Jurkat cells with an NR4Al inactivator-induced apoptosis and inhibited cell growth. The in vitro characterization of NR4Al as pro-oncogenic in leukemia cells is in contrast to the tumor suppressor-like activity of NR4Al in transgenic mouse models, and these differences are currently being investigated.
CITATION STYLE
Safe, S., Lee, S. O., Meng, C., & Zhou, B. (2015). Nr4a orphan receptors as drug targets. In Targeted Therapy of Acute Myeloid Leukemi (pp. 509–528). Springer New York. https://doi.org/10.1007/978-1-4939-1393-0_26
Mendeley helps you to discover research relevant for your work.